Recent Disclosures by Five Major Pharmaceutical Firms Regarding Drug and Supplement Litigation
January 13, 2002
photo-7
Johnson & Johnson
The N.J.-based pharmaceutical giant reports that it faces a multitude of lawsuits stemming from the use of Propulsid, which was manufactured by subsidiary Janssen Pharmaceuticals. In the wake of publicity following the withdraw of Propulsid from general sales in 2000, the company says, more than 700 lawsuit comprising claims filed by more than 2,800 people have been filed in state and federal courts across the county. A significant number of these cases are class actions and accuse Janssen of inadequately testing for and warning about the drug's side effects, of promoting the drug for …
UPCOMING CONFERENCES
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach